
Mary Trott
About Mary Trott
Data last updated:
Mary Trott is a Director at Beaukev Pharma International Private Limited (since 2016) and Director at Global Studyhub Opc Private Limited (since 2015). The companies operate in Pharma and Education. The 2 current companies with reported revenue have a combined latest revenue of ₹3.85 Cr; the largest is Beaukev Pharma International Private Limited at ₹3.85 Cr (FY 2024).
Current companies
| Company | Designation | Appointment | Founded | Revenue | Status |
|---|---|---|---|---|---|
| Director | 12 Feb 2016 | 2016 | ₹3.85 Cr (FY 2024) | Active | |
| Director | 15 Jan 2015 | 2015 | ₹30,000 (FY 2025) | Active |
Board colleagues of Mary Trott
| Name | DIN | Company | Designation |
|---|---|---|---|
| Kevin Lawrence Trott | 07436657 | Beaukev Pharma International Private Limited | Director |
Directorship timeline
Open interactive timeline →Shareholding and investment profile for Mary Trott
Company-level share counts, filed values, and quarterly changes require authenticated premium access.
- Company-level holdings
- Filed share counts
- Reported values
- Quarterly changes
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Mary Trott
Mary Trott currently holds 2 directorships: Beaukev Pharma International Private Limited (Director, since 12 Feb 2016, revenue ₹3.85 Cr (FY 2024)); Global Studyhub Opc Private Limited (Director, since 15 Jan 2015, revenue ₹30,000 (FY 2025)).
Mary Trott was first appointed on 15 Jan 2015 as Director at Global Studyhub Opc Private Limited. The most recent appointment on record is 12 Feb 2016 at Beaukev Pharma International Private Limited.
The 2 current companies of Mary Trott that report revenue have a combined latest revenue of ₹3.85 Cr: Beaukev Pharma International Private Limited ₹3.85 Cr (FY 2024); Global Studyhub Opc Private Limited ₹30,000 (FY 2025).
The current boards of Mary Trott's companies include Kevin Lawrence Trott (Beaukev Pharma International Private Limited).